Go Deep
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,397 | 21.8 | 2.57 | 0.32 | 205.93 |
Kilitch Drugs (India) Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 448,788,000.0 | 896,027,000.0 | 538,080,000.0 | 489,245,000.0 |
| Net Profit | 29,130,000.0 | 145,185,000.0 | 44,322,000.0 | 81,897,000.0 |
| EPS | 0.8 | 4.2 | 1.2 | 2.5 |
Kilitch Drugs (India) Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 2,353,493,000.0 | 1,972,398,000.0 | 1,536,062,000.0 | 1,388,582,000.0 | — |
| Net Profit | 301,664,000.0 | 267,006,000.0 | 146,014,000.0 | 104,481,000.0 | — |
| EPS | 8.9 | 8.1 | 4.5 | 3.3 | — |
Kilitch Drugs (India) Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 4,577,492,000.0 | 3,127,838,000.0 | 2,400,616,000.0 | 2,195,213,000.0 | — |
| Total Liabilities | 1,808,821,000.0 | 1,123,258,000.0 | 643,883,000.0 | 689,414,000.0 | — |
| Total Equity | 2,796,533,000.0 | 2,023,291,000.0 | 1,762,912,000.0 | 1,515,972,000.0 | — |
Owes vs Owns
Kilitch Drugs (India) Limited owed ₹0.40 for every ₹1 it owned in Mar 2026, up from ₹0.31 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.40× | 0.36× | 0.27× | 0.31× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kilitch Drugs (India) Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 15.0%Receivables 26.3%Inventory 2.6%Fixed assets (tangible) 41.2%Intangible assets 3.9%Long-term investments 4.7%Other assets 6.3%
How it's funded — Mar 2026
Short-term debt 6.6%Long-term debt 12.8%Payables 17.4%Other liabilities 2.7%Shareholders' equity 60.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 68.7 | 59.3 | 69.0 | 59.1 |
| Receivables | 120.2 | 84.7 | 63.2 | 54.3 |
| Inventory | 12.0 | 21.6 | 5.6 | 2.4 |
| Fixed assets (tangible) | 188.7 | 92.8 | 48.1 | 47.4 |
| Intangible assets | 18.0 | 18.9 | 19.8 | 20.5 |
| Long-term investments | 21.3 | 21.1 | 21.2 | 21.3 |
| Other assets | 28.9 | 14.4 | 13.1 | 14.6 |
| Liabilities & equity | ||||
| Short-term debt | 30.1 | 21.7 | 31.6 | 22.2 |
| Long-term debt | 58.6 | 27.8 | 0.0 | 0.0 |
| Payables | 79.6 | 54.2 | 25.6 | 40.9 |
| Other liabilities | 12.5 | 8.7 | 7.2 | 5.9 |
| Shareholders' equity | 276.9 | 200.5 | 175.7 | 150.6 |
| Net tangible assets | 261.7 | 183.4 | 156.5 | 131.1 |
Kilitch Drugs (India) Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 239,576,000.0 | 175,423,000.0 | -15,350,000.0 | 25,858,000.0 | — |
| Investing Activities | -1,004,367,000.0 | -399,469,000.0 | -81,562,000.0 | 79,150,000.0 | — |
| Financing Activities | 824,525,000.0 | 132,433,000.0 | 88,067,000.0 | -7,163,100.0 | — |